The ASD market holds significant opportunities due to unmet needs for targeted treatments, given no approved therapies for core symptoms exist. With three late-stage developments and the expected ...

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

Autism advocacy groups are reacting after Mattel announced a new Barbie doll, the first with autism, on Sunday.

Background Autism spectrum disorder (ASD) is a neurodevelopmental condition characterised by impairments in social ...

After controlling for familial factors, acid-suppressive medications in pregnancy showed no association with risk for ...

XTL will acquire 85% of NeuroNOS for consideration including 19.9% of XTL's issued share capital, $1 million in cash, and milestone-based contingent payments totaling up to $32.5 million. The ...

How do we distinguish between bipolar mood disorder, cyclothymic temperament, and borderline personality disorder? This may be among the most important questions in clinical psychiatry and ...

Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcherCritical unmet need: 1 in 31 ...

Dr Nancy Carteron urges clinicians to learn to recognize how Sjӧgren disease could be hiding in plain sight and why early ...

Beyond Air (XAIR) stock surged 150% as XTL acquired 85% of NeuroNOS for $32.5M. Trading volume jumped 363% on autism treatment platform deal.

A recent study finds that certain psychiatric disorders have considerable genetic overlap. But these genes aren’t the whole story; you have a say in what they do.

XTL noted that NeuroNOS's drug development platform is designed to address the underlying molecular mechanisms driving autism ...